Related references
Note: Only part of the references are listed.Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia
Steven L. Allen et al.
LEUKEMIA RESEARCH (2010)
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG
Jan Braess et al.
BLOOD (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Auto-SCT for AML in second remission: CALGB Study 9620
C. A. Linker et al.
BONE MARROW TRANSPLANTATION (2009)
Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group
Thomas Buechner et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia
T Büchner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome
N Kroger et al.
BONE MARROW TRANSPLANTATION (2006)
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome
K van Besien et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation
J Offman et al.
BLOOD (2004)
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: Final induction results of cancer and leukemia group B study 9621
JE Kolitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
SM Smith et al.
BLOOD (2003)
Unique balanced chromosome abnormalities in treatment-related myelodysplastic syndromes and acute myeloid leukemia:: Report from an international workshop
HJ Olney et al.
GENES CHROMOSOMES & CANCER (2002)
Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop
MK Andersen et al.
GENES CHROMOSOMES & CANCER (2002)
Poor prognosis acute myelogenous leukemia: 3-biological and molecular biological changes during remission induction therapy
E Devemy et al.
LEUKEMIA RESEARCH (2001)
Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine)
HD Preisler et al.
LEUKEMIA RESEARCH (2000)
High-dose chemotherapy (CTM) for breast cancer
LE Damon et al.
BONE MARROW TRANSPLANTATION (2000)
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: A long-term study of 70 patients - Report of the French Society of Bone Marrow Transplantation
I Yakoub-Agha et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
